We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
Cap. Flow
-$8.74B
Cap. Flow %
-3.39%
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$352M
2
MRK icon
Merck
MRK
+$333M
3
NVDA icon
NVIDIA
NVDA
+$306M
4
TEAM icon
Atlassian
TEAM
+$280M
5
CTVA icon
Corteva
CTVA
+$253M

Sector Composition

Rank Sector Weight
1 Technology 22.56%
2 Healthcare 14.16%
3 Financials 12.95%
4 Consumer Discretionary 9.76%
5 Industrials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DADA
2901
DELISTED
Dada Nexus
DADA
$383K ﹤0.01%
54,900
-23,300
-30% -$122K
EYPT icon
2902
EyePoint Inc
EYPT
$1.2B
$379K ﹤0.01%
108,167
-7,234
-6% -$31.9K
FWRG icon
2903
First Watch Restaurant Group
FWRG
$766M
$379K ﹤0.01%
28,000
-49,475
-64% -$754K
NODK icon
2904
NI Holdings
NODK
$320M
$373K ﹤0.01%
28,057
-4,292
-13% -$58.5K
CLSK icon
2905
CleanSpark
CLSK
$3.16B
$372K ﹤0.01%
182,235
-12,349
-6% -$32K
CSTE icon
2906
Caesarstone
CSTE
$79.5M
$372K ﹤0.01%
65,193
-11,793
-15% -$88.1K
PAMT
2907
PAMT Corp
PAMT
$297M
$372K ﹤0.01%
14,375
CISO
2908
CISO Global
CISO
$12.1M
$371K ﹤0.01%
9,683
-434
-4% -$19.7K
NGVC icon
2909
Vitamin Cottage Natural Grocers
NGVC
$654M
$371K ﹤0.01%
40,590
-12,459
-23% -$131K
AKTS
2910
DELISTED
Akoustis Technologies Inc
AKTS
$371K ﹤0.01%
131,508
-8,174
-6% -$25.7K
DSGR icon
2911
Distribution Solutions Group
DSGR
$1.61B
$365K ﹤0.01%
19,804
NOTV
2912
DELISTED
Inotiv
NOTV
$361K ﹤0.01%
73,068
-45,176
-38% -$562K
MPX
2913
DELISTED
Marine Products Corp
MPX
$357K ﹤0.01%
30,387
-41
-0.1% -$432
CMLS
2914
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$357K ﹤0.01%
57,453
-23,272
-29% -$166K
SLQT icon
2915
SelectQuote
SLQT
$121M
$351K ﹤0.01%
521,721
-69,786
-12% -$45.7K
ABSI icon
2916
Absci
ABSI
$1.51B
$348K ﹤0.01%
165,680
-50,038
-23% -$137K
ATOM icon
2917
Atomera
ATOM
$214M
$348K ﹤0.01%
55,922
-3,570
-6% -$29.3K
FHTX icon
2918
Foghorn Therapeutics
FHTX
$360M
$345K ﹤0.01%
53,963
-3,090
-5% -$23.3K
III icon
2919
Information Services Group
III
$251M
$341K ﹤0.01%
74,151
-48,203
-39% -$244K
CONN
2920
DELISTED
Conn's Inc.
CONN
$337K ﹤0.01%
48,999
-8,390
-15% -$66.2K
NAUT icon
2921
Nautilus Biotechnolgy
NAUT
$115M
$333K ﹤0.01%
184,780
-24,486
-12% -$47.3K
CASA
2922
DELISTED
Casa Systems, Inc. Common Stock
CASA
$333K ﹤0.01%
121,880
-29,857
-20% -$87.6K
CTV
2923
DELISTED
Innovid Corp.
CTV
$331K ﹤0.01%
193,546
+73,333
+61% +$199K
KRON
2924
DELISTED
Kronos Bio
KRON
$328K ﹤0.01%
202,423
-18,621
-8% -$42.9K
CYXT
2925
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$328K ﹤0.01%
170,833
-1,405,652
-89% -$3.32M

Similar funds

Nuveen's Q4 2022 Portfolio in Review

As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nuveen opened a new position in Atlassian worth $226M.

  • Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
  • Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
  • Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
  • Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
  • Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
  • Nuveen opened 40 new positions and closed 159 in Q4 2022.
  • Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.